Search results (83)
« Back to NewsExperts hold first meeting for new international project on depression, anxiety and psychosis
23 March 2023
The Global Alliance for Living Evidence on aNxiety, depressiOn and pSychosis, or GALENOS project, has launched in central London.
Ensuring LGBTQI+ people are treated fairly in mental health data
28 February 2023
Research Highlights Strategic Developments
Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.
Life and Mind Building construction tops out
16 February 2023
Another milestone was reached this week with the topping out ceremony of the new Life and Mind Building.
Oxford spinout trials revolutionary bioelectronic implant to treat incontinence
3 February 2023
Research Highlights Strategic Developments
The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.
Director of MRC Brain Network Dynamics Unit appointed
15 December 2022
From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.
Oxford gets £122m funding for healthcare research
14 October 2022
Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.
IDRM officially opens in Oxford
20 July 2022
A celebration for the opening of the Institute of Developmental & Regenerative Medicine (IDRM) led by Paul Riley took place on Tuesday 12 July 2022, attended by many DPAG members who have recently relocated to this fantastic new Institute.
NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills
24 May 2022
Research Highlights Strategic Developments
Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.
Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment
16 May 2022
Research Highlights Strategic Developments
A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull “structural” cells, are much more complex than previously thought.
Unique study of vascular disease reaches 20th anniversary
19 April 2022
Research Highlights Strategic Developments
The only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.
New funding awarded to study persistent pain in inflammatory arthritis
25 March 2022
Major Funding Awards Strategic Developments
The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
Massive Publicity for Study of Effects of Mild COVID on Smell
7 March 2022
Research Highlights Strategic Developments
Researchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.
NIHR Awards Oxford Health Clinical Research Facility £4 million Over Next Five Years
7 March 2022
Major Funding Awards Strategic Developments
The Oxford Health Clinical Research Facility (OH CRF) is one of 28 facilities across England to benefit from nearly £161 million that has been awarded by the National Institute for Health Research (NIHR) to expand early phase clinical research delivery in NHS hospitals.
Next Radcliffe Department of Medicine Head appointed
15 February 2022
Professor Keith Channon has been appointed as the next Head of the Radcliffe Department of Medicine (RDM).
Kia Nobre steps down as Head of Department
10 January 2022
Matthew Rushworth replaces Kia Nobre as interim Head of the Department of Experimental Psychology
New spinout company: Human-Centric Drug Discovery
7 January 2022
Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.